STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.
WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...
One of the most remarkable aspects of the populist alliance between Robert F. Kennedy Jr. and Donald Trump is that it puts ...
After pledging to allow politician and vaccine skeptic Robert Francis Kennedy Jr. | Trump's appointment follows his ...
While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.
His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.
The rapid progress in AI has also facilitated real-life applications within the pharmaceutical industry that may lead to ...
The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and ...
Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...
The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...